Optimal radiotherapy utilisation rate in developing countries: An IAEA study

Eduardo Rosenblatt; Michael Barton; William Mackillop; Elena Fidarova; Lisbeth Cordero; Joel Yarney; Gerard Lim; Anthony Abad; Valentin Cernea; Suzana Stojanovic-Rundic; Primoz Strojan; Lotfi Kobachi; Aldo Quarneti

doi:10.1016/j.radonc.2015.06.012

Optimal radiotherapy utilisation rate in developing countries: An IAEA study

Radiother Oncol. 2015 Jul;116(1):35-7. doi: 10.1016/j.radonc.2015.06.012. Epub 2015 Jul 8.

Authors

Affiliations

¹ International Atomic Energy Agency, Nuclear Applications, Vienna, Austria.
² Ingham Institute for Applied Medical Research, Radiation Oncology, Sydney, Australia. Electronic address: [email protected].
³ Queen's Cancer Research Institute, Queen's University, Kingston, Canada.
⁴ Hospital Mexico, Radiotherapy, San Jose, Costa Rica.
⁵ National Centre for Radiotherapy and Nuclear Medicine, Radiotherapy, Accra, Ghana.
⁶ National Cancer Institute, Putrajaya, Malaysia.
⁷ Lung Center of the Philippines Hospital, Radiation Oncology, Quezon City, Philippines.
⁸ Radiation Oncology, Oncology Institute Cluj-Napoca, University of Medicine And Pharmacy, Cluj-Napoca, Romania.
⁹ Institute of Oncology and Radiology of Serbia, Radiation Oncology, Belgrade, Serbia.
¹⁰ Institute of Oncology, Radiation Oncology, Ljubljana, Slovenia.
¹¹ Institut National de Cancer Salah Azaiz, Radiotherapy, Tunis, Tunisia.
¹² Hospital Pereira Rossell, Radiotherapy, Montevideo, Uruguay.

PMID: 26164776
DOI: 10.1016/j.radonc.2015.06.012

Abstract

Optimal radiotherapy utilisation rate (RTU) is the proportion of all cancer cases that should receive radiotherapy. Optimal RTU was estimated for 9 Middle Income Countries as part of a larger IAEA project to better understand RTU and stage distribution.

Keywords: Middle income countries; Radiotherapy services; Radiotherapy utilisation.

MeSH terms

Developing Countries
Humans
Income
Neoplasm Staging
Neoplasms / pathology
Neoplasms / radiotherapy*